National Health Investors (NYSE:NHI) Updates FY19 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY19 earnings guidance on Thursday morning. The company provided earnings per share guidance of $5.47-5.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.47.

Shares of NYSE:NHI opened at $79.27 on Friday. National Health Investors has a twelve month low of $73.35 and a twelve month high of $86.54. The firm has a market cap of $3.58 billion, a PE ratio of 14.47, a price-to-earnings-growth ratio of 3.76 and a beta of 0.27. The company has a debt-to-equity ratio of 1.04, a quick ratio of 14.42 and a current ratio of 14.42. The business has a fifty day moving average of $83.50 and a 200-day moving average of $80.59.

National Health Investors (NYSE:NHI) last announced its earnings results on Thursday, November 7th. The real estate investment trust reported $0.97 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.42). National Health Investors had a net margin of 50.71% and a return on equity of 11.00%. The business had revenue of $81.68 million during the quarter, compared to analyst estimates of $79.96 million. During the same quarter last year, the business posted $1.39 earnings per share. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. On average, analysts anticipate that National Health Investors will post 5.49 EPS for the current fiscal year.

NHI has been the subject of a number of research reports. Zacks Investment Research lowered National Health Investors from a hold rating to a sell rating in a research note on Saturday. ValuEngine upgraded National Health Investors from a sell rating to a hold rating in a research report on Friday, October 25th. Three investment analysts have rated the stock with a sell rating and two have given a hold rating to the stock. The company presently has an average rating of Sell and a consensus price target of $79.50.

In related news, Director James R. Jobe sold 900 shares of National Health Investors stock in a transaction dated Tuesday, September 24th. The stock was sold at an average price of $83.23, for a total value of $74,907.00. Following the completion of the sale, the director now directly owns 12,052 shares in the company, valued at $1,003,087.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 5.11% of the stock is owned by company insiders.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Forex

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.